Registry update — unassessed
(Health Promotion) Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in Head and Neck Cancer Patients
Trial registry update: RECRUITING. No results reported in the supplied registry record.
RCTN=60Minor significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 17, 2026 · Discovered: Sep 17, 2026 · Assessed: — · Research update
What it does not prove
- The abstract reports no numerical findings—no effect sizes, no between-group differences, no association strengths—so no claim about the magnitude or presence of any benefit can be evaluated.
- The study measures biomarkers and their association with prognosis prediction, not clinical endpoints like survival or quality of life.
- Exercise maintaining or improving muscle mass may predict better prognosis, but causation cannot be inferred; the association itself is not yet reported.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- 60
- Duration
- —
- Population
- Head and Neck cancer patients enrolled at Chang Gung Memorial Hospital
- Primary outcome
- Skeletal muscle mass changes on images (DXA and CT)
- Effect size
- —
- Significance
- Not reported
- Journal
- Chang Gung Memorial Hospital
- Published
- Sep 17, 2026
Sources
Primary source
- Chang Gung Memorial Hospital ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 2. This is not a claim of full-text review.
This project adopts a prospective study design. It is scheduled to enroll 60 participants diagnosed with Head and Neck cancer in this hospital, of which 30 are in the experimental group and 30 are in the control group.
The purpose of this research is to analyze the skeletal muscle mass changes on images in Head and Neck cancer patients after exercise training and the association with systemic inflammatory markers.
Subjects enrolled in the trial will receive 36 times of exercise training after concurrent chemoradiotherapy.
Before and after the completion of exercise training, investigators will arrange (1) dual energy X-ray absorptiometry (DXA) to measure the whole-body skeletal muscle mass and appendicular skeletal muscle mass and (2) blood tests for markers of systemic inflammation.
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.